Study details
Enrolling now
Platelet Rich Plasma Injections in Young and Old Human Subjects
University of California, San Francisco
NCT IDNCT06451120ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
60
Study length
about 1.5 years
Ages
18–70
Locations
1 site in CA
About this study
This trial is testing platelet-rich plasma (PRP) injections for knee osteoarthritis. This is a phase 2 randomized, double-blind, placebo-controlled trial with a secondary crossover phase at the end of the initial trial to ensure all subjects receive one PRP injection. The goal is to identify what proteins change in the blood following repeated intraarticular knee PRP injections in patients with knee osteoarthritis.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Control saline injection
- 2.Take Platelet-Rich Plasma (PRP) Injections
- 3.Use Centrifuge
PhasePhase 2
Routeinjection
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug routes
injection
Body systems
Musculoskeletal